|
Quotes & Info
|
| TRMS > SEC Filings for TRMS > Form 8-K on 17-Feb-2009 | All Recent SEC Filings |
17-Feb-2009
Other Events
On February 16, 2009, Hoffmann-La Roche ("Roche") informed its U.S. wholesalers and specialty pharmacy distributors that it was increasing the price of FUZEON. The wholesale acquisition cost of a one-year supply of FUZEON was increased by 9.0% to approximately $29,700. Under our collaboration agreement with Roche, Roche retains sole responsibility for pricing of FUZEON.
|
|